Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Compliance Training will lead the strategy, design, and execution of a global compliance training program for a biotechnology organization. This role is responsible for fostering a culture of ethics and compliance by delivering engaging, risk-based training aligned with regulatory requirements and industry best practices. The ideal candidate brings deep expertise in life sciences compliance, adult learning methodologies, and global training program management. This role will work closely with Learning & Development, Corporate Communications, Legal, HR, and business stakeholders to integrate compliance and legal training into broader enterprise learning, communications, and change-management efforts.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior